Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjec (Q33158973)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjec |
scientific article |
Statements
1 reference
Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjec (English)
1 reference
Akiko Sarashina
1 reference
Shogo Sesoko
1 reference
Mitsuyoshi Nakashima
1 reference
Naoyuki Hayashi
1 reference
Atsushi Taniguchi
1 reference
Yoshiharu Horie
1 reference
Eva U Graefe-Mody
1 reference
Hans-Juergen Woerle
1 reference
Klaus A Dugi
1 reference
1 reference
Identifiers
1 reference